RxDoctor Payments Data

Nicole Melet

Medical · San Francisco, CANPI 1477657971

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 801 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,891in general payments, 2019–2025

Across 801 payments — averaging $23.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$4K
  • AbbVie$3K
  • LEO Pharma Inc.$3K
  • Lilly USA, LLC$2K
  • Sanofi$1K
  • Sun Pharmaceutical Industries Inc.$765
  • plus $6K from 21 others

What the payments were for

  • Travel & lodging$90%
  • Food & beverage$18,39797%
  • Education$4843%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,891 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.

See all medical providers in California

Medicare billing

Part B allowed, 2024
$135,945
Medicare patients
337
Services billed
2,454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab12$42,540
Ciclopirox58$2,077
Fluorouracil37$1,967
Desonide35$1,418
Sulfacetamide Sodium13$1,213
Clobetasol Propionate27$901
Ketoconazole54$860
Metronidazole14$653
Triamcinolone Acetonide46$521
Doxycycline Hyclate25$513
Clindamycin Phosphate18$497
ValacyclovirValacyclovir Hcl16$285
Hydrocortisone11$115

Paid to pharmacies, not to this prescriber.

Other medical in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →